Tada S - Search Results

1

Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites.

Hiraku Y, Inoue S, Oikawa S, Yamamoto K, Tada S, Nishino K, Kawanishi S. Hiraku Y, et al. Among authors: tada s. Carcinogenesis. 1995 Feb;16(2):349-56. doi: 10.1093/carcin/16.2.349. Carcinogenesis. 1995. PMID: 7859368

2

Simple reaction times and timing of serial reactions of adolescents with mental retardation, autism, and Down syndrome.

Inui N, Yamanishi M, Tada S. Inui N, et al. Among authors: tada s. Percept Mot Skills. 1995 Dec;81(3 Pt 1):739-45. doi: 10.2466/pms.1995.81.3.739. Percept Mot Skills. 1995. PMID: 8668429

3

Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.

Kaneko F, Saito H, Saito Y, Wakabayashi K, Nakamoto N, Tada S, Suzuki H, Tsunematsu S, Kumagai N, Ishii H. Kaneko F, et al. Among authors: tada s. Int J Oncol. 2004 Apr;24(4):837-45. Int J Oncol. 2004. PMID: 15010820

4

Influence of implant design and bone quality on stress/strain distribution in bone around implants: a 3-dimensional finite element analysis.

Tada S, Stegaroiu R, Kitamura E, Miyakawa O, Kusakari H. Tada S, et al. Int J Oral Maxillofac Implants. 2003 May-Jun;18(3):357-68. Int J Oral Maxillofac Implants. 2003. PMID: 12814310

5

Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.

Wakabayashi K, Saito H, Kaneko F, Nakamoto N, Tada S, Hibi T. Wakabayashi K, et al. Among authors: tada s. Int J Oncol. 2005 Jan;26(1):233-9. Int J Oncol. 2005. PMID: 15586245

6

Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.

Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, Toda K, Yamada T, Kumagai N, Saito H, Hibi T. Nakamoto N, et al. Among authors: tada s. Int J Oncol. 2006 Sep;29(3):625-35. Int J Oncol. 2006. PMID: 16865278

7

The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C.

Saito H, Tada S, Wakabayashi K, Nakamoto N, Takahashi M, Nakamura M, Ebinuma H, Ishii H. Saito H, et al. Among authors: tada s. J Interferon Cytokine Res. 2002 Jun;22(6):693-700. doi: 10.1089/10799900260100196. J Interferon Cytokine Res. 2002. PMID: 12162881

8

Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.

Nakamoto N, Saito H, Ebinuma H, Tada S, Saito Y, Kurita S, Kitamura K, Ishii H. Nakamoto N, et al. Among authors: tada s. Intern Med. 2003 Apr;42(4):322-30. doi: 10.2169/internalmedicine.42.322. Intern Med. 2003. PMID: 12729320 Free article.

9

A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury.

Nakamoto N, Tada S, Kameyama K, Kitamura K, Kurita S, Saito Y, Saito H, Ishii H. Nakamoto N, et al. Among authors: tada s. Free Radic Res. 2003 Aug;37(8):849-59. doi: 10.1080/1071576031000136586. Free Radic Res. 2003. PMID: 14567445

10

Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis.

Saito Y, Saito H, Tada S, Nakamoto N, Horikawa H, Kurita S, Kitamura K, Ebinuma H, Ishii H, Hibi T. Saito Y, et al. Among authors: tada s. Hepatogastroenterology. 2005 Sep-Oct;52(65):1491-6. Hepatogastroenterology. 2005. PMID: 16201104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

974 results

Search Page

Filters